<DOC>
	<DOC>NCT02448199</DOC>
	<brief_summary>Phase III Study, double-blind, comparing association of anti-inflammatory and anti-rheumatic in 375 subjects with knee osteoarthritis.</brief_summary>
	<brief_title>Study of Association of Anti-inflammatory and Anti-rheumatic</brief_title>
	<detailed_description>Evaluation after 12 weeks of treatment, in 3 arms, the efficacy and safety of the association.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Signs the Informed Consent Form Age between 40 and 85 years osteoarthritis of the knee according to clinical and radiological criteria of the American College of Rheumatology Cardiovascular disease Serious chronic comorbidity Hypersensitivity to any component of the study drugs body mass index&gt; 30 kg / mÂ²</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>pain</keyword>
	<keyword>Knee</keyword>
</DOC>